You Make the Call

You Make the Call

Each month we’ll pick a challenging clinical question submitted through the Consult-a-Colleague program and post the expert’s response.

How would you manage VTE risk in a transgender patient who needs hormone replacement...

This month, Kenneth A. Bauer, MD, discusses venous thromboembolism (VTE) risk in a transgender patient who needs hormone replacement therapy. And don't forget to check...

How would you treat a pregnant patient with type 2A von Willebrand disease?

This month Margaret V. Ragni, MD, MPH, discusses treatment options for a pregnant patient with type 2A von Willebrand disease. And don't forget to check out...

How would you treat an older patient with pancytopenia who was diagnosed with ALL?

This month Jonathan E. Kolitz, MD, discusses treating a patient with acute lymphocytic leukemia who is of advanced age. And don't forget to check out...

How should you treat a patient with lymphoma who developed “chemo brain” after R-CHOP...

This month, Carol S. Portlock, MD, discusses neurologic toxicity following R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone). And don't forget to check out next month's clinical dilemma...

What are treatment options for a pregnant woman with iron deficiency who has had...

This month Michael Auerbach, MD, discusses treatment options for a pregnant woman with iron deficiency who has had bariatric surgery. And don't forget to check...

From ASH Meeting on Hematologic Malignancies: What is the prognosis for symptomatic, bulky FL...

During their presentations, MHM speakers will be asking the audience how they would respond to patient cases. Audience members will vote live at the...

From ASH Meeting on Hematologic Malignancies: How would you use molecular diagnostic tests to...

During their presentations, MHM speakers will be asking the audience how they would respond to patient cases. Audience members will vote live at the...

Is this case of deep vein thrombosis provoked or unprovoked?

This month Beth Battinelli, MD, PhD, discusses thrombosis development after extended travel. And don’t forget to check out next month’s clinical dilemma – send in your responses for...

From ASH Meeting on Hematologic Malignancies: How would you treat MDS that has not...

During their presentations, MHM speakers will be asking the audience how they would respond to patient cases. Audience members will vote live at the...

How would you treat a patient with aplastic anemia who refuses transfusions for religious...

This month, Neil A. Zakai, MD, discusses how to treat a patient with aplastic anemia who has religious objections to allogeneic blood product. And don't...
Advertisement

Current Issue

February 2018 Volume 4, Issue 3

This issue features a conversation with National Cancer Institute Director Norman “Ned” Sharpless, MD, a look at the prevalence and controversial nature of academic-industry partnerships, and more.